PIPA173075

Chlamydia trachomatis MOMP Polyclonal Antibody, Biotin, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA173075-Each-of-1 In Stock ₹ 47,036.50

PIPA173075 - Each of 1

₹ 47,036.50

In Stock

Quantity

1

Base Price: ₹ 47,036.50

GST (18%): ₹ 8,466.57

Total Price: ₹ 55,503.07

Antigen

Chlamydia trachomatis MOMP

Classification

Polyclonal

Conjugate

Biotin

Gene Alias

C. trachomatis MOMP; Chlamydia MOMP

Immunogen

Purified MOMP from L2 strain

Quantity

1 mL

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Immunocytochemistry

Concentration

4-5 mg/mL

Formulation

PBS with 0.1% sodium azide, pH 7.2

Host Species

Goat

Purification Method

IgG fraction

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA173073

--

Img

Thermo Scientific

PIPA173068

--

Img

Thermo Scientific

PIPA173066

--

Img

Thermo Scientific

PIPA173070

--

Img

Thermo Scientific

PIPA173074

--

Img

Thermo Scientific

PIPA173072

--

Img

Thermo Scientific

PIPA127200

--

Img

Thermo Scientific

PIPA173150

--

Description

  • The PA1-73075 antibody reacts with Chlamydia trachomatis major outer membrane protein (MOMP)
  • This antibody does not cross react with C
  • psittacii or C
  • pneumoniae in MIF
  • PA1-73075 has been successfully used in immunofluorescence applications against all serovars (A-K, L1-L3)
  • The PA1-73075 antibody was raised against C
  • trachomatis serovars (A-K, L1-L3)
  • Chlamydia trachomatis is an intracellular organism
  • Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men
  • Chlamydial infections are believed to be one of the most common of all STDs
  • It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year
  • Thus, there are many undiagnosed cases of chlamydia in the community
  • It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%
  • Chlamydia is one of the leading causes of blindness in underdeveloped countries.